MET and neoplasm: Analysis of signaling pathways by GSEA and gene expression analysis revealed that AZD4547-resistant tumor cells had enhanced c-Met signaling and higher FGF18 and FGF19 mRNA expression compared with AZD4547-sensitive cells.